大塚ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/08 | 3,851 | 3,887 | 3,831 | 3,837 | -54 | -1.4% | 885,200 |
| 2022/03/07 | 3,900 | 3,908 | 3,847 | 3,891 | -47 | -1.2% | 852,100 |
| 2022/03/04 | 3,971 | 3,982 | 3,923 | 3,938 | -7 | -0.2% | 759,900 |
| 2022/03/03 | 3,900 | 3,957 | 3,888 | 3,945 | +71 | +1.8% | 758,100 |
| 2022/03/02 | 3,868 | 3,891 | 3,852 | 3,874 | -64 | -1.6% | 944,900 |
| 2022/03/01 | 4,015 | 4,029 | 3,931 | 3,938 | -25 | -0.6% | 988,900 |
| 2022/02/28 | 3,935 | 3,987 | 3,935 | 3,963 | +31 | +0.8% | 1,186,200 |
| 2022/02/25 | 3,936 | 3,949 | 3,892 | 3,932 | +28 | +0.7% | 882,500 |
| 2022/02/24 | 3,957 | 3,961 | 3,871 | 3,904 | -82 | -2.1% | 1,076,700 |
| 2022/02/22 | 4,024 | 4,024 | 3,932 | 3,986 | -44 | -1.1% | 616,700 |
| 2022/02/21 | 4,019 | 4,043 | 3,989 | 4,030 | -23 | -0.6% | 483,500 |
| 2022/02/18 | 3,972 | 4,057 | 3,971 | 4,053 | +52 | +1.3% | 871,400 |
| 2022/02/17 | 4,006 | 4,030 | 3,954 | 4,001 | -43 | -1.1% | 1,091,600 |
| 2022/02/16 | 4,022 | 4,057 | 4,008 | 4,044 | +46 | +1.2% | 831,000 |
| 2022/02/15 | 3,999 | 4,032 | 3,972 | 3,998 | +34 | +0.9% | 798,200 |
| 2022/02/14 | 3,988 | 4,044 | 3,954 | 3,964 | -118 | -2.9% | 955,400 |
| 2022/02/10 | 4,080 | 4,099 | 4,025 | 4,082 | +17 | +0.4% | 1,157,100 |
| 2022/02/09 | 4,124 | 4,124 | 4,050 | 4,065 | -46 | -1.1% | 867,400 |
| 2022/02/08 | 4,122 | 4,139 | 4,092 | 4,111 | +20 | +0.5% | 712,100 |
| 2022/02/07 | 4,040 | 4,099 | 4,029 | 4,091 | +34 | +0.8% | 579,200 |
| 2022/02/04 | 4,017 | 4,063 | 4,005 | 4,057 | +17 | +0.4% | 630,000 |
| 2022/02/03 | 3,992 | 4,040 | 3,980 | 4,040 | +35 | +0.9% | 895,800 |
| 2022/02/02 | 3,934 | 4,031 | 3,929 | 4,005 | +101 | +2.6% | 1,187,600 |
| 2022/02/01 | 3,918 | 3,959 | 3,898 | 3,904 | -14 | -0.4% | 942,700 |
| 2022/01/31 | 3,910 | 3,941 | 3,845 | 3,918 | -45 | -1.1% | 1,386,600 |
| 2022/01/28 | 4,064 | 4,080 | 3,951 | 3,963 | -129 | -3.2% | 1,831,800 |
| 2022/01/27 | 4,166 | 4,173 | 4,054 | 4,092 | -42 | -1% | 667,300 |
| 2022/01/26 | 4,183 | 4,192 | 4,124 | 4,134 | -69 | -1.6% | 883,800 |
| 2022/01/25 | 4,180 | 4,203 | 4,138 | 4,203 | +2 | ±0% | 790,900 |
| 2022/01/24 | 4,153 | 4,206 | 4,145 | 4,201 | +48 | +1.2% | 779,000 |
| 2022/01/21 | 4,123 | 4,170 | 4,101 | 4,153 | +23 | +0.6% | 569,700 |
| 2022/01/20 | 4,087 | 4,182 | 4,087 | 4,130 | +55 | +1.3% | 761,500 |
| 2022/01/19 | 4,109 | 4,130 | 4,057 | 4,075 | -56 | -1.4% | 856,700 |
| 2022/01/18 | 4,164 | 4,190 | 4,126 | 4,131 | -17 | -0.4% | 549,900 |
| 2022/01/17 | 4,119 | 4,178 | 4,113 | 4,148 | +62 | +1.5% | 668,800 |
| 2022/01/14 | 4,131 | 4,154 | 4,076 | 4,086 | -138 | -3.3% | 1,368,100 |
| 2022/01/13 | 4,241 | 4,253 | 4,202 | 4,224 | -48 | -1.1% | 898,100 |
| 2022/01/12 | 4,250 | 4,284 | 4,231 | 4,272 | +37 | +0.9% | 1,115,300 |
| 2022/01/11 | 4,284 | 4,333 | 4,195 | 4,235 | -13 | -0.3% | 1,283,200 |
| 2022/01/07 | 4,237 | 4,249 | 4,210 | 4,248 | +36 | +0.9% | 1,002,400 |
| 2022/01/06 | 4,260 | 4,266 | 4,192 | 4,212 | -27 | -0.6% | 791,800 |
| 2022/01/05 | 4,211 | 4,254 | 4,197 | 4,239 | +17 | +0.4% | 750,100 |
| 2022/01/04 | 4,184 | 4,230 | 4,171 | 4,222 | +53 | +1.3% | 887,100 |
| 2021/12/30 | 4,187 | 4,215 | 4,165 | 4,169 | -56 | -1.3% | 706,600 |
| 2021/12/29 | 4,238 | 4,251 | 4,205 | 4,225 | -74 | -1.7% | 605,500 |
| 2021/12/28 | 4,261 | 4,299 | 4,256 | 4,299 | +54 | +1.3% | 960,200 |
| 2021/12/27 | 4,270 | 4,272 | 4,233 | 4,245 | -39 | -0.9% | 711,500 |
| 2021/12/24 | 4,300 | 4,300 | 4,252 | 4,284 | +6 | +0.1% | 513,900 |
| 2021/12/23 | 4,263 | 4,278 | 4,241 | 4,278 | +11 | +0.3% | 486,100 |
| 2021/12/22 | 4,263 | 4,276 | 4,255 | 4,267 | +20 | +0.5% | 614,000 |
851～
900
件表示中 / 3596件
類似銘柄と比較する
現在ご覧いただいている「大塚ＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大塚ＨＤ | 789,300円 | +2.2% | +28.0% | 1.77% | 12.63倍 | 1.53倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| 武 田 | 440,200円 | -1.1% | +75.3% | 4.54% | 30.49倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 第一三共 | 358,800円 | +6.0% | +4.0% | 2.17% | 22.14倍 | 4.09倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| アステラス薬 | 162,900円 | +0.9% | +380.2% | 4.79% | 22.44倍 | 1.93倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 254,000円 | +20.9% | +10.6% | 2.60% | 12.01倍 | 1.59倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム
